Strive Financial Group’s Pfizer PFE Stock Holding History

Strive Financial Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-27	Closed	-$7K	–	940
2026 Q1	$7K	Buy	+27	New	+$719	﹤0.01%	465

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Strive Financial Group's PFE Position: Q2 2026 in Review

Strive Financial Group increased its Pfizer (PFE) stake by 30% in Q2 2026, buying an estimated $57.8K and bringing the position to 9,474 shares worth $228K. The position accounts for 0.1% of the portfolio, ranked #133.

Strive Financial Group first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. 2,109 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Strive Financial Group held 9,474 shares of Pfizer worth $228K as of Q2 2026.
Strive Financial Group bought 2,208 Pfizer shares in Q2 2026, an estimated $57.8K.
Pfizer made up 0.1% of Strive Financial Group's portfolio in Q2 2026, its #133 holding.
Strive Financial Group first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
2,109 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Strive Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.